Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00234026
Status:
COMPLETED
Last Update Posted:
2012-06-05
First Post:
2005-10-05
Brief Title:
Gemcitabine in Treating Patients With Newly Diagnosed Relapsed or Chemotherapy-Resistant Mantle Cell Lymphoma
Sponsor:
Swiss Group for Clinical Cancer Research
Organization:
Swiss Group for Clinical Cancer Research
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-06
Start Date Type:
None
Primary Completion Date:
2006-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-03
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-05
First Submit QC Date:
October 5 2005
Study First Post Date:
2005-10-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-06-04
Last Update Post Date:
2012-06-05
Last Update Post Date Type:
ESTIMATED